GSO ISO 16900-1:2024

ISO 16900-1:2019
Gulf Standard   Current Edition · Approved on 25 April 2024

Respiratory protective devices — Methods of test and test equipment — Part 1: Determination of inward leakage

GSO ISO 16900-1:2024 Files

English 37 Pages
Current Edition Reference Language
72.84 BHD

GSO ISO 16900-1:2024 Scope

This document specifies the test methods for determining inward leakage of respiratory interfaces (RI) and total inward leakage of complete respiratory protective devices (RPD) using specified test agents and incorporating specified body movements, at specified metabolic work rates.

These tests are conducted in laboratories using specific test agents under specified conditions and therefore do not indicate the performance of the device in actual use.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
BH GSO 2017:2023
GSO 2017:2023 
Bahraini Standard
Personal Care and Baby Wet Wipes
BH GSO 2241:2023
GSO 2241:2023 
Bahraini Standard
Cosmetic Products - Body Cleaners
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners

Recently Published from Health Sector

GSO ISO 20776-2:2024
ISO 20776-2:2021 
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution
GSO ISO 27186:2024
ISO 27186:2020 
Gulf Standard
Active implantable medical devices — Four-pole connector system for implantable cardiac rhythm management devices — Dimensional and test requirements
GSO ISO 28620:2024
ISO 28620:2020 
Gulf Standard
Medical devices — Non-electrically driven portable infusion devices
GSO ISO 20776-1:2024
ISO 20776-1:2019 
Gulf Standard
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases